Update in rheumatology: evidence published in 2012

MeSH terms

• Anti-Inflammatory Agents / therapeutic use*
• Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
• Antibodies, Monoclonal, Humanized / therapeutic use*
• Antibodies, Monoclonal, Murine-Derived / therapeutic use*
• Antirheumatic Agents / adverse effects*
• Antirheumatic Agents / therapeutic use*
• Antiviral Agents / therapeutic use*
• Arthritis / drug therapy*
• Arthritis, Gouty / drug therapy*
• Arthritis, Rheumatoid / drug therapy*
• Autoimmune Diseases / complications*
• Bacterial Infections / diagnosis*
• Calcitonin / blood*
• Colchicine / therapeutic use*
• Cryoglobulinemia / drug therapy*
• Cryoglobulinemia / therapy*
• Death, Sudden, Cardiac / epidemiology*
• Drug Resistance, Viral / drug effects*
• Enzyme Inhibitors / therapeutic use*
• Female
• Gout / therapy*
• Gout Suppressants / therapeutic use*
• Hand Joints*
• Hepatitis C, Chronic / drug therapy*
• Humans
• Hyperuricemia / therapy*
• Immunologic Factors / therapeutic use*
• Janus Kinase 3 / antagonists & inhibitors*
• Male
• Myocardial Infarction / mortality*
• Neoplasms / chemically induced*
• Osteoarthritis / therapy*
• Osteoarthritis, Hip / therapy*
• Osteoarthritis, Knee / therapy*
• Practice Guidelines as Topic*
• Protein Precursors / blood*
• Pyrimidines / therapeutic use*
• Pyrroles / therapeutic use*
• Registries / statistics & numerical data*
• Tumor Necrosis Factor-alpha / antagonists & inhibitors*